US House Drug Pricing Hearings Start Slow As Pharma Execs Dodge Some Punches

 
• By Cathy Kelly

Bristol Myers Squibb CEO Giovanni Caforio, former Celgene CEO Mark Alles and Teva CEO Kare Schultz fielded roughly four hours of questioning at an oversight hearing on pricing practices for Revlimid and Copaxone.

Washington DC Capitol dome detail with waving american flag
More Drug Pricing Hearings To Come

More from Pricing Debate

More from Market Access